— Know what they know.
Not Investment Advice

OFIX NASDAQ

Orthofix Medical Inc.
1W: -15.3% 1M: -14.2% 3M: -24.9% YTD: -29.9% 1Y: -13.2% 3Y: -42.8% 5Y: -75.5%
$10.75
+0.34 (+3.27%)
 
Weekly Expected Move ±5.3%
$11 $11 $12 $13 $13
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 33 · $434.5M mcap · 40M float · 0.759% daily turnover · Short 55% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
57.5 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -4.4%  ·  5Y Avg: -18.4%
Cost Advantage
64
Intangibles
65
Switching Cost
46
Network Effect
78
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. OFIX has a Narrow competitive edge (57.5/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. Negative ROIC of -4.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$12
Low
$15
Avg Target
$18
High
Based on 4 analysts since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 9Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$15.60
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-22 Barrington $18 $15 -3 +44.1% $10.41
2026-05-22 UBS Initiated $15 +44.1% $10.41
2026-05-21 Cowen & Co. Initiated $12 +15.3% $10.41
2026-05-21 Canaccord Genuity Caitlin Burrows Initiated $18 +72.9% $10.41
2026-03-09 Stifel Nicolaus $22 $18 -4 +44.5% $12.46
2025-11-05 Barrington Michael Petusky Initiated $18 +21.5% $14.81
2025-10-28 Stifel Nicolaus $24 $22 -2 +36.5% $16.12
2024-11-08 Stifel Nicolaus Mathew Blackman $31 $24 -7 +31.7% $18.22
2022-06-28 Stifel Nicolaus Mathew Blackman Initiated $31 +28.6% $24.11

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. OFIX receives an overall rating of C. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-11 C- C
2026-04-01 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

30 Grade D
Profitability
20
Balance Sheet
57
Earnings Quality
44
Growth
70
Value
41
Momentum
67
Safety
30
Cash Flow
22
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. OFIX scores highest in Growth (70/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.25
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
-2.89
Unlikely Manipulator
Ohlson O-Score
-7.15
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BB-
Score: 37.2/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -0.58x
Accruals: -10.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. OFIX scores 1.25, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. OFIX scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. OFIX's score of -2.89 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. OFIX's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. OFIX receives an estimated rating of BB- (score: 37.2/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-7.25x
PEG
-0.07x
P/S
0.53x
P/B
1.00x
P/FCF
-127.85x
P/OCF
13.29x
EV/EBITDA
6.37x
EV/Revenue
0.74x
EV/EBIT
-15.52x
EV/FCF
-168.42x
Earnings Yield
-12.93%
FCF Yield
-0.78%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. OFIX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.008
NI / EBT
×
Interest Burden
1.511
EBT / EBIT
×
EBIT Margin
-0.048
EBIT / Rev
×
Asset Turnover
0.947
Rev / Assets
×
Equity Multiplier
1.830
Assets / Equity
=
ROE
-12.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. OFIX's ROE of -12.6% is driven by Asset Turnover (0.947), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$10.75
Median 1Y
$7.76
5th Pctile
$3.76
95th Pctile
$16.25
Ann. Volatility
44.1%
Analyst Target
$15.60
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Massimo Calafiore -
President and Chief Executive Officer
$848,322 $4,499,988 $7,310,039
Julie Andrews -
Chief Financial Officer
$488,428 $1,762,507 $3,017,844
J. Andrés Cedrón
- Chief Legal Officer
$483,287 $900,008 $2,057,964
Aviva McPherron -
President, Global Operations and Quality
$447,297 $900,008 $1,811,906
Patrick Fisher -
President, Global Biologics and Limb Reconstruction
$462,721 $749,990 $1,796,906

CEO Pay Ratio

26:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,310,039
Avg Employee Cost (SGA/emp): $284,353
Employees: 1,605

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,605
-0.7% YoY
Revenue / Employee
$512,344
Rev: $822,312,000
Profit / Employee
$-57,440
NI: $-92,192,000
SGA / Employee
$284,353
Avg labor cost proxy
R&D / Employee
$35,584
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -2.4% -4.4% -11.1% -10.7% -10.7% -13.1% -5.9% -22.6% -35.1% -40.5% -32.4% -27.0% -25.8% -25.4% -22.9% -26.0% -22.5% -21.6% -19.3% -12.6% -12.59%
ROA -1.6% -2.9% -7.7% -7.4% -7.4% -9.1% -4.2% -16.3% -25.3% -29.1% -21.9% -18.3% -17.4% -17.2% -13.9% -15.7% -13.6% -13.1% -10.6% -6.9% -6.88%
ROIC -2.8% -14.8% -2.4% -2.4% -1.8% -3.3% -3.4% -17.9% -29.1% -33.9% -16.1% -12.6% -11.2% -10.6% -11.2% -13.7% -12.6% -12.3% -9.1% -4.4% -4.40%
ROCE 4.8% 2.9% -3.1% -2.7% -3.2% -5.1% -4.4% -19.1% -29.7% -34.5% -18.4% -14.7% -13.5% -12.8% -13.0% -15.4% -13.0% -12.5% -10.8% -5.8% -5.79%
Gross Margin 77.4% 74.8% 73.4% 73.4% 73.2% 73.2% 73.0% 63.0% 63.9% 65.1% 68.2% 67.5% 67.8% 68.7% 69.0% 62.8% 68.7% 72.2% 64.6% 70.9% 70.94%
Operating Margin 3.5% -0.3% -7.5% -2.9% 5.6% -5.1% -9.0% -34.1% -19.6% -13.3% -9.1% -15.6% -12.5% -9.6% -5.3% -25.2% -7.9% -8.3% 6.1% -7.0% -6.96%
Net Margin 2.0% -1.9% -26.2% -4.2% 2.1% -9.4% -5.8% -34.8% -21.1% -15.7% -11.1% -19.1% -16.8% -13.9% -13.5% -27.4% -6.9% -11.1% -1.0% -10.6% -10.63%
EBITDA Margin 11.3% 5.3% -0.7% 4.0% 9.1% -0.7% 1.1% -25.5% -11.6% -6.8% -0.3% -7.6% -6.0% -2.4% 5.8% -6.2% 3.8% -1.5% 41.6% -0.1% -0.10%
FCF Margin 5.9% 2.6% -0.2% -2.6% -3.4% -5.6% -7.5% -12.7% -12.5% -13.4% -14.6% -12.2% -9.7% -6.0% -1.1% -0.6% 0.1% -0.4% -0.1% -0.4% -0.44%
OCF Margin 9.8% 6.3% 4.0% 1.8% 1.2% -0.5% -2.5% -7.1% -6.4% -5.5% -6.1% -4.0% -2.1% -0.6% 3.2% 3.2% 3.5% 3.6% 4.2% 4.2% 4.23%
ROE 3Y Avg snapshot only -20.96%
ROE 5Y Avg snapshot only -19.30%
ROA 3Y Avg snapshot only -12.25%
ROIC 3Y Avg snapshot only -13.89%
ROIC Economic snapshot only -3.97%
Cash ROA snapshot only 4.10%
Cash ROIC snapshot only 5.85%
CROIC snapshot only -0.61%
NOPAT Margin snapshot only -3.19%
Pretax Margin snapshot only -7.21%
R&D / Revenue snapshot only 7.44%
SGA / Revenue snapshot only 67.36%
SBC / Revenue snapshot only 5.12%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -98.49 -50.43 -16.09 -17.57 -12.81 -8.44 -21.00 -7.85 -5.62 -3.51 -3.32 -4.33 -4.18 -5.05 -5.36 -4.47 -3.56 -4.89 -6.58 -7.73 -7.247
P/S Ratio 1.76 1.65 1.33 1.40 1.02 0.83 0.90 1.13 1.11 0.72 0.67 0.72 0.65 0.77 0.85 0.79 0.54 0.71 0.74 0.56 0.526
P/B Ratio 2.24 2.11 1.83 1.93 1.41 1.14 1.23 1.78 1.97 1.42 0.84 0.92 0.84 1.00 1.34 1.27 0.88 1.16 1.35 1.03 0.999
P/FCF 29.74 63.78 -552.75 -53.54 -29.75 -14.67 -11.95 -8.91 -8.90 -5.35 -4.60 -5.91 -6.72 -12.70 -74.37 -133.17 955.37 -200.75 -1250.07 -127.85 -127.845
P/OCF 17.99 26.00 33.42 78.16 84.71 26.20 24.60 15.37 19.82 17.77 13.29 13.289
EV/EBITDA 12.93 14.73 25.84 25.52 20.42 23.93 24.62 -17.09 -9.65 -5.80 -7.37 -12.88 -14.99 -21.86 -42.32 -46.22 145.75 128.91 8.95 6.37 6.367
EV/Revenue 1.60 1.49 1.19 1.26 0.89 0.69 0.84 1.08 1.06 0.67 0.78 0.83 0.76 0.87 0.97 0.91 0.66 0.83 0.92 0.74 0.741
EV/EBIT 35.61 55.19 -47.51 -58.33 -34.64 -17.02 -23.48 -7.97 -5.69 -3.48 -4.18 -5.66 -5.74 -7.06 -8.19 -6.61 -5.70 -7.52 -10.28 -15.52 -15.520
EV/FCF 27.09 57.74 -495.87 -48.31 -25.76 -12.24 -11.11 -8.48 -8.51 -5.02 -5.37 -6.82 -7.84 -14.47 -84.98 -153.25 1164.46 -233.99 -1553.60 -168.42 -168.416
Earnings Yield -1.0% -2.0% -6.2% -5.7% -7.8% -11.9% -4.8% -12.7% -17.8% -28.5% -30.2% -23.1% -23.9% -19.8% -18.6% -22.4% -28.1% -20.5% -15.2% -12.9% -12.93%
FCF Yield 3.4% 1.6% -0.2% -1.9% -3.4% -6.8% -8.4% -11.2% -11.2% -18.7% -21.7% -16.9% -14.9% -7.9% -1.3% -0.8% 0.1% -0.5% -0.1% -0.8% -0.78%
Price/Tangible Book snapshot only 2.545
EV/OCF snapshot only 17.507
EV/Gross Profit snapshot only 1.073
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.60 2.60 2.55 2.55 2.55 2.55 3.06 3.06 3.06 3.06 2.54 2.54 2.54 2.54 2.57 2.57 2.57 2.57 2.45 2.45 2.445
Quick Ratio 1.79 1.79 1.76 1.76 1.76 1.76 1.86 1.86 1.86 1.86 1.20 1.20 1.20 1.20 1.45 1.45 1.45 1.45 2.24 2.24 2.245
Debt/Equity 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.06 0.20 0.20 0.20 0.20 0.36 0.36 0.36 0.36 0.51 0.51 0.509
Net Debt/Equity -0.20 -0.20 -0.19 -0.19 -0.19 -0.19 -0.09 -0.09 -0.09 -0.09 0.14 0.14 0.14 0.14 0.19 0.19 0.19 0.19 0.33 0.33 0.327
Debt/Assets 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.13 0.13 0.13 0.13 0.20 0.20 0.20 0.20 0.27 0.27 0.270
Debt/EBITDA 0.44 0.54 1.13 1.06 1.21 1.82 1.38 -0.65 -0.33 -0.28 -1.47 -2.39 -2.98 -3.74 -9.85 -11.29 48.77 34.12 2.72 2.39 2.388
Net Debt/EBITDA -1.27 -1.54 -2.96 -2.76 -3.16 -4.75 -1.86 0.88 0.44 0.38 -1.06 -1.71 -2.14 -2.68 -5.28 -6.06 26.17 18.31 1.75 1.53 1.534
Interest Coverage 9.62 6.76 -6.35 -5.61 -7.16 -12.59 -12.75 -32.44 -36.44 -29.65 -16.23 -9.38 -6.57 -5.05 -3.18 -3.76 -3.29 -3.22 -4.19 -2.11 -2.112
Equity Multiplier 1.47 1.47 1.41 1.41 1.41 1.41 1.36 1.36 1.36 1.36 1.55 1.55 1.55 1.55 1.78 1.78 1.78 1.78 1.89 1.89 1.890
Cash Ratio snapshot only 0.481
Debt Service Coverage snapshot only 5.148
Cash to Debt snapshot only 0.358
FCF to Debt snapshot only -0.016
Defensive Interval snapshot only 131.8 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.89 0.89 0.93 0.93 0.92 0.92 0.99 1.13 1.28 1.43 1.08 1.10 1.12 1.13 0.88 0.88 0.89 0.90 0.94 0.95 0.947
Inventory Turnover 1.30 1.33 1.37 1.40 1.45 1.48 1.35 1.75 2.14 2.51 1.62 1.59 1.57 1.55 1.23 1.28 1.28 1.26 2.42 2.29 2.287
Receivables Turnover 5.72 5.74 6.15 6.16 6.12 6.14 5.71 6.56 7.41 8.28 7.08 7.21 7.32 7.44 6.08 6.12 6.16 6.23 6.08 6.10 6.104
Payables Turnover 5.05 5.15 4.64 4.73 4.90 4.99 4.57 5.92 7.25 8.50 6.06 5.98 5.89 5.83 4.73 4.93 4.93 4.84 5.05 4.77 4.772
DSO 64 64 59 59 60 59 64 56 49 44 52 51 50 49 60 60 59 59 60 60 59.8 days
DIO 281 275 266 261 252 247 271 209 171 146 226 229 232 235 296 284 285 289 151 160 159.6 days
DPO 72 71 79 77 74 73 80 62 50 43 60 61 62 63 77 74 74 75 72 76 76.5 days
Cash Conversion Cycle 272 268 247 243 237 234 255 203 169 147 217 219 220 221 279 270 270 273 139 143 142.9 days
Operating Cycle snapshot only 219.4 days
Cash Velocity snapshot only 10.062
Capital Intensity snapshot only 1.031
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 10.3% 11.4% 14.2% 14.2% 1.4% 1.4% -0.8% 13.8% 29.5% 44.2% 62.1% 43.5% 28.9% 17.3% 7.1% 5.9% 4.8% 4.3% 2.9% 2.6% 2.59%
Net Income 62.4% -1.6% -16.2% -27.8% -3.6% -2.0% 48.5% -1.1% -2.2% -2.0% -6.7% -65.9% -2.0% 12.7% 16.8% -13.1% -2.7% -0.1% 26.8% 58.1% 58.06%
EPS 63.7% -1.6% -15.9% -25.4% -3.5% -2.0% 49.4% -14.6% -74.9% -61.6% -3.2% -57.1% 1.4% 15.5% 19.9% -8.9% 1.2% 3.1% 29.2% 59.4% 59.35%
FCF -21.5% -74.1% -1.0% -1.3% -1.6% -3.2% -30.1% -4.5% -3.7% -2.4% -2.1% -37.9% -0.7% 47.2% 91.7% 94.8% 1.0% 93.9% 94.7% 24.4% 24.41%
EBITDA 1.5% 75.6% -52.6% -33.5% -64.4% -71.1% -27.0% -2.4% -4.3% -6.8% -6.1% -47.2% 40.3% 59.6% 77.0% 67.5% 1.1% 1.2% 5.6% 7.0% 7.03%
Op. Income 1.3% 1.8% -32.7% 47.1% -1.7% -3.4% -59.6% -7.2% -17.5% -10.4% -9.5% -55.5% 14.3% 30.6% 39.2% 4.2% 1.8% -2.1% 19.1% 68.0% 68.04%
OCF Growth snapshot only 34.31%
Asset Growth snapshot only -4.77%
Equity Growth snapshot only -10.55%
Debt Growth snapshot only 27.63%
Shares Change snapshot only 3.19%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.0% 0.6% 0.8% 0.9% 0.3% 0.3% 0.1% 5.1% 13.2% 17.7% 22.5% 23.1% 19.2% 19.7% 19.8% 20.0% 20.5% 20.8% 21.3% 15.9% 15.95%
Revenue 5Y 2.2% 2.4% 2.5% 2.4% 2.0% 1.7% 1.2% 3.8% 6.2% 8.3% 10.5% 10.9% 11.0% 11.3% 11.7% 12.0% 14.4% 14.8% 15.1% 15.2% 15.17%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y -0.3% -4.8% -24.6% -14.4% -20.3% -31.0% -17.8% -43.2% -26.7% 75.2%
EBITDA 5Y 6.7% -0.5% -15.0% -13.4% -14.7% -22.0% -23.5% -30.3% -27.6% 13.2% 22.7% 22.65%
Gross Profit 3Y -0.1% -0.8% -0.6% -0.9% -1.7% -1.9% -2.1% 1.3% 8.5% 12.1% 16.9% 18.4% 14.3% 15.5% 16.0% 15.8% 17.0% 18.0% 17.8% 15.5% 15.53%
Gross Profit 5Y 1.7% 1.6% 1.7% 1.3% 0.6% 0.4% -0.2% 1.4% 2.9% 4.4% 6.4% 7.1% 7.6% 8.2% 8.7% 8.7% 11.6% 12.4% 12.6% 13.5% 13.46%
Op. Income 3Y -39.6% -49.4%
Op. Income 5Y -10.4% -25.8%
FCF 3Y -13.6% -35.6%
FCF 5Y -2.7% -19.3% -57.8%
OCF 3Y -7.8% -20.9% -28.2% -45.9% -50.2% 11.8% 46.2% 72.4%
OCF 5Y -4.4% -12.1% -16.2% -28.2% -30.0% -4.2% -10.6% -11.8% -14.4% -14.4% -11.5% -11.48%
Assets 3Y 9.1% 9.1% 0.7% 0.7% 0.7% 0.7% -2.6% -2.6% -2.6% -2.6% 20.7% 20.7% 20.7% 20.7% 23.3% 23.3% 23.3% 23.3% 22.9% 22.9% 22.87%
Assets 5Y 5.6% 5.6% 5.1% 5.1% 5.1% 5.1% 2.5% 2.5% 2.5% 2.5% 14.7% 14.7% 14.7% 14.7% 12.5% 12.5% 12.5% 12.5% 10.1% 10.1% 10.10%
Equity 3Y 6.4% 6.4% 0.2% 0.2% 0.2% 0.2% 0.9% 0.9% 0.9% 0.9% 18.8% 18.8% 18.8% 18.8% 14.3% 14.3% 14.3% 14.3% 10.1% 10.1% 10.14%
Book Value 3Y 4.4% 4.1% -1.2% -1.0% -2.0% -1.8% -0.6% -17.8% -18.7% -18.8% -4.4% -4.6% -4.2% -4.8% -8.5% -8.8% -8.7% -9.0% -12.3% 5.7% 5.68%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.26 0.22 0.18 0.16 0.35 0.25 0.13 0.37 0.50 0.46 0.44 0.56 0.66 0.69 0.68 0.79 0.90 0.91 0.86 0.91 0.911
Earnings Stability 0.28 0.07 0.43 0.65 0.74 0.26 0.42 0.93 0.73 0.57 0.57 0.93 0.84 0.67 0.63 0.96 0.82 0.83 0.57 0.36 0.356
Margin Stability 0.98 0.98 0.98 0.97 0.97 0.97 0.97 0.95 0.94 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.94 0.94 0.94 0.95 0.954
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.500
FCF Positive Streak 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.20 0.20 0.89 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.99 0.95 0.93 0.95 0.99 1.00 0.89 0.50 0.500
Earnings Smoothness
ROE Trend -0.00 -0.03 -0.07 -0.06 -0.07 -0.15 -0.01 -0.13 -0.28 -0.32 -0.17 -0.04 0.03 0.07 -0.09 -0.07 0.03 0.06 0.05 0.11 0.114
Gross Margin Trend -0.01 -0.01 -0.01 -0.01 -0.03 -0.03 -0.02 -0.05 -0.08 -0.09 -0.09 -0.06 -0.03 -0.01 -0.01 -0.01 0.00 0.01 0.00 0.02 0.023
FCF Margin Trend -0.01 -0.05 -0.09 -0.11 -0.11 -0.12 -0.14 -0.17 -0.14 -0.12 -0.11 -0.05 -0.02 0.03 0.10 0.12 0.11 0.09 0.08 0.06 0.060
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -5.47 -1.94 -0.48 -0.22 -0.15 0.05 0.58 0.50 0.33 0.27 0.30 0.24 0.13 0.04 -0.20 -0.18 -0.23 -0.25 -0.37 -0.58 -0.582
FCF/OCF 0.61 0.41 -0.06 -1.46 -2.85 12.42 3.01 1.77 1.94 2.44 2.38 3.06 4.74 10.21 -0.35 -0.18 0.02 -0.10 -0.01 -0.10 -0.104
FCF/Net Income snapshot only 0.060
OCF/EBITDA snapshot only 0.364
CapEx/Revenue 3.9% 3.8% 4.2% 4.4% 4.7% 5.2% 5.0% 5.5% 6.0% 7.9% 8.5% 8.2% 7.7% 5.4% 4.4% 3.8% 3.5% 3.9% 4.2% 4.7% 4.67%
CapEx/Depreciation snapshot only 0.285
Accruals Ratio -0.10 -0.09 -0.11 -0.09 -0.08 -0.09 -0.02 -0.08 -0.17 -0.21 -0.15 -0.14 -0.15 -0.17 -0.17 -0.19 -0.17 -0.16 -0.14 -0.11 -0.109
Sloan Accruals snapshot only -0.176
Cash Flow Adequacy snapshot only 0.906
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -1.1% -1.3% -1.4% -1.1% -1.4% -1.3% -1.0% -0.7% -0.6% -0.9% -1.0% -0.9% -1.2% -1.0% -0.9% -1.0% -1.4% -1.0% -1.0% -1.3% -1.27%
Total Shareholder Return -1.1% -1.3% -1.4% -1.1% -1.4% -1.3% -1.0% -0.7% -0.6% -0.9% -1.0% -0.9% -1.2% -1.0% -0.9% -1.0% -1.4% -1.0% -1.0% -1.3% -1.27%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) -0.86 -8.90 2.84 3.12 2.74 2.24 1.12 1.04 1.03 1.02 1.02 1.02 1.02 1.02 1.02 1.02 1.01 1.01 1.02 1.01 1.008
Interest Burden (EBT/EBIT) 0.46 0.14 1.16 1.18 1.14 1.08 1.08 1.03 1.03 1.03 1.06 1.11 1.15 1.20 1.31 1.27 1.30 1.31 1.24 1.51 1.511
EBIT Margin 0.04 0.03 -0.03 -0.02 -0.03 -0.04 -0.04 -0.13 -0.19 -0.19 -0.19 -0.15 -0.13 -0.12 -0.12 -0.14 -0.12 -0.11 -0.09 -0.05 -0.048
Asset Turnover 0.89 0.89 0.93 0.93 0.92 0.92 0.99 1.13 1.28 1.43 1.08 1.10 1.12 1.13 0.88 0.88 0.89 0.90 0.94 0.95 0.947
Equity Multiplier 1.49 1.49 1.44 1.44 1.44 1.44 1.39 1.39 1.39 1.39 1.48 1.48 1.48 1.48 1.65 1.65 1.65 1.65 1.83 1.83 1.830
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.41 $-0.76 $-1.93 $-1.86 $-1.84 $-2.26 $-0.98 $-2.13 $-3.21 $-3.66 $-4.07 $-3.35 $-3.17 $-3.09 $-3.26 $-3.65 $-3.13 $-3.00 $-2.30 $-1.48 $-1.48
Book Value/Share $17.90 $18.05 $16.97 $16.93 $16.75 $16.77 $16.68 $9.43 $9.16 $9.04 $16.08 $15.86 $15.75 $15.56 $13.00 $12.83 $12.74 $12.65 $11.25 $11.13 $10.76
Tangible Book/Share $10.65 $10.74 $10.72 $10.70 $10.59 $10.60 $10.80 $6.10 $5.93 $5.86 $7.69 $7.59 $7.53 $7.44 $5.41 $5.34 $5.30 $5.27 $4.56 $4.51 $4.51
Revenue/Share $22.85 $23.12 $23.39 $23.38 $22.97 $23.07 $22.81 $14.82 $16.28 $17.95 $20.05 $20.14 $20.30 $20.38 $20.66 $20.52 $20.48 $20.57 $20.56 $20.40 $20.40
FCF/Share $1.35 $0.60 $-0.06 $-0.61 $-0.79 $-1.30 $-1.72 $-1.88 $-2.03 $-2.41 $-2.93 $-2.46 $-1.97 $-1.23 $-0.23 $-0.12 $0.01 $-0.07 $-0.01 $-0.09 $-0.09
OCF/Share $2.23 $1.47 $0.93 $0.42 $0.28 $-0.10 $-0.57 $-1.06 $-1.05 $-0.99 $-1.23 $-0.80 $-0.42 $-0.12 $0.67 $0.66 $0.73 $0.74 $0.85 $0.86 $0.86
Cash/Share $4.83 $4.87 $4.42 $4.41 $4.37 $4.37 $2.51 $1.42 $1.38 $1.36 $0.89 $0.88 $0.87 $0.86 $2.15 $2.12 $2.11 $2.09 $2.05 $2.03 $2.97
EBITDA/Share $2.83 $2.34 $1.08 $1.16 $1.00 $0.67 $0.78 $-0.93 $-1.79 $-2.08 $-2.13 $-1.30 $-1.03 $-0.81 $-0.47 $-0.41 $0.09 $0.13 $2.11 $2.37 $2.37
Debt/Share $1.25 $1.26 $1.22 $1.22 $1.21 $1.21 $1.07 $0.60 $0.59 $0.58 $3.14 $3.10 $3.08 $3.04 $4.64 $4.58 $4.55 $4.52 $5.73 $5.67 $5.67
Net Debt/Share $-3.58 $-3.61 $-3.20 $-3.19 $-3.16 $-3.16 $-1.44 $-0.82 $-0.79 $-0.78 $2.26 $2.22 $2.21 $2.18 $2.49 $2.46 $2.44 $2.42 $3.68 $3.64 $3.64
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.254
Altman Z-Prime snapshot only 1.393
Piotroski F-Score 6 4 3 3 3 2 4 3 3 3 3 3 4 4 6 4 5 5 4 5 5
Beneish M-Score -2.80 -2.98 -3.04 -2.94 -2.89 -2.91 -2.54 -2.58 -3.03 -3.21 -2.21 -2.27 -2.32 -2.37 -3.26 -3.31 -3.27 -3.28 -2.96 -2.89 -2.887
Ohlson O-Score snapshot only -7.152
ROIC (Greenblatt) snapshot only -16.74%
Net-Net WC snapshot only $0.40
EVA snapshot only $-86021660.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 89.44 86.81 64.96 60.53 54.66 49.16 56.02 62.46 63.09 56.20 40.77 40.38 40.97 40.23 41.07 40.63 27.13 31.48 36.84 37.23 37.233
Credit Grade snapshot only 13
Credit Trend snapshot only -3.395
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 33
Sector Credit Rank snapshot only 26

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms